SU 6668 was produced to inhibit the VEGF receptor and FGFR with the goal of inhibiting tumour progress by suppressing

angiogenesis, but it has just lately been discovered to bind to and inhibit numerous other protein kinases, which includes Aurora kinases, TBK1 and AMPK. When profiled against our prolonged panel, we identified that SU 6668 inhibited not only these protein kinases, but a quantity of other folks. MKK1, CHK2, ERK8, RSK1, RSK2, S6K1, Aurora B and Aurora C ended up the protein kinases inhibited most potently.